OutcomeImprovementEffect · pTreatmentControl
risk of mechanical ventilation
98.5% lower · RR 0.02 · p < 0.001***
98.5% lowerRR 0.02p < 0.001***
0 of 350 (0.0%)
32 of 336 (9.5%)
treatment 0 of 350 (0.0%), control 32 of 336 (9.5%)combined bromhexine armsNNT 10continuity correction due to zero eventsday 28
risk of mechanical ventilation
98.2% lower · RR 0.02 · p < 0.001***
98.2% lowerRR 0.02p < 0.001***
0 of 350 (0.0%)
27 of 336 (8.0%)
treatment 0 of 350 (0.0%), control 27 of 336 (8.0%)combined bromhexine armsNNT 12continuity correction due to zero eventsday 14
risk of mechanical ventilation
97.5% lower · RR 0.03 · p < 0.001***
97.5% lowerRR 0.03p < 0.001***
0 of 350 (0.0%)
19 of 336 (5.7%)
treatment 0 of 350 (0.0%), control 19 of 336 (5.7%)combined bromhexine armsNNT 18continuity correction due to zero eventsday 9
risk of oxygen therapy
99.7% lower · RR 0.00 · p < 0.001***
99.7% lowerRR 0.00p < 0.001***
0 of 350 (0.0%)
171 of 336 (50.9%)
treatment 0 of 350 (0.0%), control 171 of 336 (50.9%)combined bromhexine armsNNT 2.0continuity correction due to zero eventsday 28
risk of oxygen therapy
99.7% lower · RR 0.00 · p < 0.001***
99.7% lowerRR 0.00p < 0.001***
0 of 350 (0.0%)
150 of 336 (44.6%)
treatment 0 of 350 (0.0%), control 150 of 336 (44.6%)combined bromhexine armsNNT 2.2continuity correction due to zero eventsday 14
risk of oxygen therapy
99.6% lower · RR 0.00 · p < 0.001***
99.6% lowerRR 0.00p < 0.001***
0 of 350 (0.0%)
117 of 336 (34.8%)
treatment 0 of 350 (0.0%), control 117 of 336 (34.8%)combined bromhexine armsNNT 2.9continuity correction due to zero eventsday 9
risk of hospitalization
98.5% lower · RR 0.02 · p < 0.001***
98.5% lowerRR 0.02p < 0.001***
0 of 350 (0.0%)
32 of 336 (9.5%)
treatment 0 of 350 (0.0%), control 32 of 336 (9.5%)combined bromhexine armsNNT 10continuity correction due to zero eventsday 28
risk of hospitalization
98.2% lower · RR 0.02 · p < 0.001***
98.2% lowerRR 0.02p < 0.001***
0 of 350 (0.0%)
27 of 336 (8.0%)
treatment 0 of 350 (0.0%), control 27 of 336 (8.0%)combined bromhexine armsNNT 12continuity correction due to zero eventsday 14
risk of hospitalization
97.5% lower · RR 0.03 · p < 0.001***
97.5% lowerRR 0.03p < 0.001***
0 of 350 (0.0%)
19 of 336 (5.7%)
treatment 0 of 350 (0.0%), control 19 of 336 (5.7%)combined bromhexine armsNNT 18continuity correction due to zero eventsday 9
risk of long COVID
55.1% lower · RR 0.45 · p < 0.001***
55.1% lowerRR 0.45p < 0.001***
157 of 350 (44.9%)
336 of 336 (100.0%)
treatment 157 of 350 (44.9%), control 336 of 336 (100.0%)combined bromhexine armsNNT 1.8day 90